van Gastel, Nick http://orcid.org/0000-0002-0563-3590
Scadden, David T.
Article History
First Online: 25 February 2021
Competing interests
: D.T.S. is a director and equity holder of Agios Pharmaceuticals, Magenta Therapeutics, Editas Medicines, Clear Creek Bio and LifeVaultBio; he is a founder of Fate Therapeutics and Magenta Therapeutics and a consultant to FOG Pharma, VCanBio and Flagship Pioneering. N.v.G. has no competing interests to declare.